Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients

Epidemiology and Infection

Volumn 134, Issue 2, 2006, Pages 265-269

  Li, S Y ^a   Yang, Y L ^b   Chen, K W ^a   Cheng, H H ^c   Chiou, C S ^a   Wang, T H ^a   Lauderdale, T L ^c   Hung, C C ^d   Lo, H J ^c  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; FLUCONAZOLE; GENOMIC DNA; NYSTATIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; COMORBIDITY; DISEASE ASSOCIATION; DNA FINGERPRINTING; DOSE RESPONSE; FUNGAL COLONIZATION; FUNGAL STRAIN; FUNGUS ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LONG TERM CARE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; PULSED FIELD GEL ELECTROPHORESIS; THRUSH;

ADULT; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DNA FINGERPRINTING; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; FLUCONAZOLE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED;

EID: 33244486781     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268805004905     Document Type: Article

References (21)

1. Pappas PG, Rex JH, Lee J, et al. A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 2003; 37: 634-643.
2. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382-402.
3. Yang YL, Lo H-J. Mechanisms of antifungal agent resistance. J Microbiol Immunol Infect 2001; 34: 79-86.
4. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167: 1247-1251.
5. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. Diagn Microbiol Infect Dis 1998; 30: 121-129.
6. Chen YC, Chang SC, Sun CC, Yang LS, Hsieh WC, Luh KT. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol 1997; 18: 369-375.
7. Holmberg K, Meyer RD. Fungal infections in patients with AIDS and AIDS-related complex. Scand J Infect Dis 1986; 18: 179-192.
8. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984; 311: 354-358.
9. Vanden Bossche H, Marichal P, Odds FC. Molecular mechanisms of drug resistance in fungi. Trends Microbiol 1994; 2: 393-400.
10. Dromer F, Improvisi L, Dupont B, et al. Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates. AIDS 1997; 11: 1095-1101.
11. Makarova NU, Pokrowsky VV, Kravchenko AV, et al. Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility. J Clin Microbiol 2003; 41: 1833-1837.
12. Hung CC, Yang YL, Lauderdale TL, et al. Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J Clin Microbiol 2005; 43: 1600-1603.
13. National Committee of Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. M27A, 1997.
14. Hsu MC, Chen KW, Lo HJ, et al. Species identification of medically important fungi by use of real-time LightCycler PCR. J Med Microbiol 2003; 52: 1071-1076.
15. Chen KW, Lo HJ, Lin YH, Li SY. Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan. J Med Microbiol 2005; 54: 249-258.
16. Perepnikhatka V, Fischer FJ, Niimi M, et al. Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans. J Bacteriol 1999; 181: 4041-4049.
17. Xu J, Ramos AR, Vilgalys R, Mitchell TG. Clonal and spontaneous origins of fluconazole resistance in Candida albicans. J Clin Microbiol 2000; 38: 1214-1220.
18. Pittet D, Monod M, Filthuth I, Frenk E, Suter PM, Auckenthaler R. Contour-clamped homogeneous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections. Am J Med 1991; 91 (Suppl): 256S-263S.
19. Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990; 28: 2733-2738.
20. Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 1994; 32: 975-980.
21. Feigal DW, Katz MH, Greenspan D, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: Three San Francisco epidemiological cohorts. AIDS 1991; 5: 519-525.